|
|
|
|
Common osteoporosis drugs are associated with a decrease in risk of breast cancer
Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by U.S.researchers published today in the British Journal of Cancer. The study found that women who used...
|
|
|
Research and Markets: Paget's Disease - Drug Pipeline Analysis and Market Forecasts to 2016
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6d28af/pagets_disease) has announced the addition of GlobalData's new report "" to their offering.The report is an essential source of information and analysis on the...
|
|
|
Certain bone drugs may lower breast cancer risk
Some types of bone-building drugs used to prevent and treat osteoporosis might reduce the risk of breast cancer, according to new research.The study, which included 6,000 Wisconsin women 20-69, found that those who took bisphosphonate drugs such as ...
|
|
|
The Sanders Firm is Assigned the First Fosamax Trial
The FDA issues another warning concerning the osteoporosis drug Fosamax as prepares for the first jury trial against the pharmaceutical giant Merck.We are ready and eager to have our day in court and hold Merck responsible for the suffering it caused...
|
|
|
Certain bone drugs may lower breast cancer risk
Some types of bone-building drugs used to prevent and treat osteoporosis might reduce the risk of breast cancer, according to new research.The study, which included 6,000 Wisconsin women 20-69, found that those who took bisphosphonate drugs such as ...
|
|
|
FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and atypical subtrochanteric femur fractures
Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Safety Announcement [03-10-2010] Patients and healthcare professionals may have questions about oral bisphosphonate medications and atypical...
|
|
|
FDA to Review Bone Drugs After Studies Report Hip Breaks
Health Blog HOME PAGE Share: Text Size There have long been safety questions and lawsuits over whether bone-building drugs like Merck's Fosamax can actually increase the chance of femur fractures.Today, the FDA said it was going to take another look at...
|
|
|
Fosamax Linked to Femur Fractures
Your Legal Guide Your Legal Guide / Your Legal Guide (PRLEAP.COM) Your Legal Guide, a leading source of consumer legal information, includes an in-depth section on Fosamax, a type of bisphosphonate drug that is used to treat diseases of the bone,...
|
|
|
FDA to Investigate Osteoporosis Drug Risk
The U.S.Food and Drug Administration announced today that it will look into whether a link exists between the long-term use of certain osteoporosis drugs and a particular type of leg fracture after ABC News reports investigated the possible connection.
|
|
|
FDA: No Connection Between Oral Bisphosphonates, Atypical Subtrochanteric Femur Fractures
-- The US Food and Drug Administration is notifying healthcare professionals and patients that at this point, the data that FDA has reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.
|
|
|
FDA will continue review of bisphosphonate, femur fracture risk
The FDA has ruled out a suggested link between bisphosphonate use and risk for atypical subtrochanteric femur fractures.Recent news reports have raised the question about whether there is an increased risk in this type of fracture in patients with...
|
|
|
FDA Drug Safety Communication: Ongoing Safety Review of Oral bisphosphonates and atypical subtrochanteric Femu
[03-10-2010] Patients and healthcare professionals may have questions about oral bisphosphonate medications and atypical subtrochanteric femur fractures fractures in the bone just below the hip joint.Oral bisphosphonates are commonly prescribed to prevent or...
|
|
|
FDA: No Clear Evidence Linking Bisphosphonates and Fractures
WASHINGTON - After headlines emerged Wednesday about new data linking prolonged bisphosphonate use to an increased risk of atypical femur fractures, the FDA rushed to assure prescribers and the public that the agency has yet to find a clear connection.
|
|
|
FDA: No Clear Evidence Linking Bisphosphonates and Fractures
WASHINGTON - After headlines emerged Wednesday about new data linking prolonged bisphosphonate use to an increased risk of atypical femur fractures, the FDA rushed to assure prescribers and the public that the agency has yet to find a clear connection.
|
|
|
FDA: No Clear Evidence Linking Bisphosphonates and Fractures
WASHINGTON - After headlines emerged Wednesday about new data linking prolonged bisphosphonate use to an increased risk of atypical femur fractures, the FDA rushed to assure prescribers and the public that the agency has yet to find a clear connection.
|
|
|
FDA Still Has a Bone to Pick With These Drugmakers
Back in 2008, the Food and Drug Administration began reviewing bisphosphonate drugs for a possible connection between the osteoporosis drugs and atypical subtrochanteric femur fractures -- a break in the thigh bone just below the hip joint.There's good news...
|
|
|
Bone drugs might cause bone breaks
EST Health More>> The Latest from HealthDay More>> Stephanie Bell Flynt | email WASHINGTON, DC (WLBT) - Bisphosphonates are designed to build bone mass and are commonly prescribed to treat osteoporosis.Two studies show long-term use of the drugs...
|
|
|
Merck Responds to News Reports about Fosamax (alendronate sodium) Tablets
-ABC News has run stories this week about bisphosphonates including FOSAMAX that miss several key points which we believe viewers and online readers should know.The FDA's statement on these stories is available here: http://www.fda.gov/Drugs/DrugSafety...
|
|
|
Long Term Fosamax Use May Cause Brittle Bones in Some Women
Mounting evidence is suggesting that using Fosamax, a popular drug prescribed to women suffering from osteoporosis, for more than five years may be causing brittle bones that are more susceptible to fractures in some women Mounting evidence is showing...
|
|
|
FDA rules out Fosamax, thigh fracture link
BOSTON - U.S.regulators said they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc.'s Fosamax and certain thigh bone fractures. The U.S. Food and Drug Administration issued its statement Wednesday...
|
|
|
CORRECTED-UPDATE 2-FDA rules out bisphosphonate, thigh fracture link
By Toni Clarke BOSTON, March 10 (Reuters) - U.S.regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc's Fosamax and certain thigh bone fractures. The U.S. Food and Drug...
|
|
|
CORRECTED-UPDATE 2-FDA rules out bisphosphonate, thigh fracture link
BOSTON, March 10 (Reuters) - U.S.regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck&Co Inc's Fosamax and certain thigh bone fractures. The U.S. Food and Drug Administration...
|
|
|
FDA rules out bisphosphonate, thigh fracture link
BOSTON (Reuters) - U.S.regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc's Fosamax and certain thigh bone fractures. The Food and Drug Administration issued its...
|
|
|
UPDATE 2-FDA rules out bisphosphonate, thigh fracture link
By Toni Clarke BOSTON, March 10 (Reuters) - U.S.regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc's Fosamax and certain thigh bone fractures. The U.S. Food and Drug...
|
|
|
UPDATE 2-FDA rules out bisphosphonate, thigh fracture link
BOSTON, March 10 (Reuters) - U.S.regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck&Co Inc's Fosamax and certain thigh bone fractures. The U.S. Food and Drug Administration...
|
